Literature DB >> 3430059

Intestinal apoB synthesis, lipids, and lipoproteins in chylomicron retention disease.

E Levy1, Y Marcel, R J Deckelbaum, R Milne, G Lepage, E Seidman, M Bendayan, C C Roy.   

Abstract

Chylomicron retention disease is characterized by fat malabsorption, hypocholesterolemia, normal fasting triglycerides, and marked intestinal steatosis despite the presence of both plasma and intestinal apoprotein B. The defect remains unknown but presumably involves the synthesis or secretion of chylomicrons. The present investigation examines this hypothesis by studying the biosynthesis of chylomicrons in cultured jejunal explants and by defining the quantitative and qualitative abnormalities of plasma lipids and of circulating lipoproteins. Following 2-3 years of a low fat diet supplemented with medium chain triglycerides, six patients with chylomicron retention disease had significantly higher triglyceride (TG) levels coupled with a decrease in both free (FC) and esterified cholesterol (EC) as well as in essential fatty acids and phospholipids (PL) when compared to healthy controls. The low total plasma cholesterol was largely accounted for by low levels of both low density (LDL) and high density lipoprotein (HDL) cholesterol. VLDL and LDL were characterized by a diminished percentage of CE with an increase of TG while HDL contained relatively more FC as well as PL and less CE. The diameter of VLDL was larger whereas those of LDL and HDL were smaller than in normal controls. Jejunal explants, when incubated with [14C]palmitate, were capable of normal biosynthesis of TG, diglycerides, PL, and CE. These lipids, however, except for PL, were retained in the tissue and could not be secreted into the culture medium. Incubation of intestinal biopsies with [3H]leucine and [14C]mannose resulted in normal protein synthesis and reduced glycosylation. The presence of intestinal apoB-48 was confirmed by immunoblot using 2D8 antibodies. These data suggest that the intestinal defect in this disease results from a disorder of the final assembly of chylomicrons or in the mechanism of their exocytosis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3430059

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  13 in total

Review 1.  Apolipoproteins in lipid transport, an impressionist view.

Authors:  D W Erkelens
Journal:  Postgrad Med J       Date:  1989-05       Impact factor: 2.401

2.  Overproduction of intestinal lipoprotein containing apolipoprotein B-48 in Psammomys obesus: impact of dietary n-3 fatty acids.

Authors:  E Levy; S Spahis; E Ziv; A Marette; M Elchebly; M Lambert; E Delvin
Journal:  Diabetologia       Date:  2006-06-21       Impact factor: 10.122

Review 3.  Insights from human congenital disorders of intestinal lipid metabolism.

Authors:  Emile Levy
Journal:  J Lipid Res       Date:  2014-11-11       Impact factor: 5.922

4.  Human small-intestinal apolipoprotein B-48 oligosaccharide chains.

Authors:  W V Sasak; J S Lown; K A Colburn
Journal:  Biochem J       Date:  1991-02-15       Impact factor: 3.857

5.  Biosynthetic precursor (214 kDa) of apolipoprotein B-48 is not secreted by Caco-2 cells and normal human intestine.

Authors:  W V Sasak; H A Buller; R Reinhold
Journal:  Biochem J       Date:  1989-12-01       Impact factor: 3.857

Review 6.  Mechanisms and genetic determinants regulating sterol absorption, circulating LDL levels, and sterol elimination: implications for classification and disease risk.

Authors:  Sebastiano Calandra; Patrizia Tarugi; Helen E Speedy; Andrew F Dean; Stefano Bertolini; Carol C Shoulders
Journal:  J Lipid Res       Date:  2011-08-23       Impact factor: 5.922

7.  Localization, function and regulation of the two intestinal fatty acid-binding protein types.

Authors:  Emile Levy; Daniel Ménard; Edgard Delvin; Alain Montoudis; Jean-François Beaulieu; Geneviève Mailhot; Nadia Dubé; Daniel Sinnett; Ernest Seidman; Moise Bendayan
Journal:  Histochem Cell Biol       Date:  2009-06-05       Impact factor: 4.304

8.  Anderson's disease: genetic exclusion of the apolipoprotein-B gene in two families.

Authors:  M Pessah; P Benlian; I Beucler; N Loux; J Schmitz; C Junien; R Infante
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

9.  Molecular analysis and intestinal expression of SAR1 genes and proteins in Anderson's disease (Chylomicron retention disease).

Authors:  Amandine Georges; Jessica Bonneau; Dominique Bonnefont-Rousselot; Jacqueline Champigneulle; Jean P Rabès; Marianne Abifadel; Thomas Aparicio; Jean C Guenedet; Eric Bruckert; Catherine Boileau; Alain Morali; Mathilde Varret; Lawrence P Aggerbeck; Marie E Samson-Bouma
Journal:  Orphanet J Rare Dis       Date:  2011-01-14       Impact factor: 4.123

10.  The endoplasmic reticulum coat protein II transport machinery coordinates cellular lipid secretion and cholesterol biosynthesis.

Authors:  Lee G D Fryer; Bethan Jones; Emma J Duncan; Claire E Hutchison; Tozen Ozkan; Paul A Williams; Olivia Alder; Max Nieuwdorp; Anna K Townley; Arjen R Mensenkamp; David J Stephens; Geesje M Dallinga-Thie; Carol C Shoulders
Journal:  J Biol Chem       Date:  2013-12-13       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.